Treatment of Ph+ ALL in AYA: Pediatric vs Adult Outcomes

Created using ChatSlide

This lecture covers Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL), emphasizing its significance in Adolescent and Young Adult (AYA) populations. Key topics include comparing pediatric and adult outcomes, standard treatments like TKIs and chemotherapy, and innovative strategies such as chemo-free induction. Insights from the GIMEMA ALL2820 trial will be discussed, highlighting its methodology, findings, and implications for tailoring therapies to optimize outcomes...